CADIAN CAPITAL MANAGEMENT, LP – Blueprint Medicines Corporation Transaction History
CADIAN CAPITAL MANAGEMENT, LP portfolio value:
$96.16M
portfolio value
CADIAN CAPITAL MANAGEMENT, LP quarter portfolio value change:
+30.45%
quarter
Blueprint Medicines Corporation 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -27.77% | -561.19K shares | -5.9M | $65.89 | 1.45M |
| Q2 2022 | share | Increase | +5.17% | 99.28K shares | -20.67M | $50.51 | 2.02M |
| Q1 2022 | share | Increase | +326.34% | 1.47M shares | 74.46M | $63.88 | 1.92M |
| Q4 2021 | share | Decrease | -57.17% | -601.54K shares | -59.90M | $109.45 | 450.65K |
| Q3 2021 | share | Decrease | -20.37% | -269.11K shares | -8.04M | $102.81 | 1.05M |
| Q2 2021 | share | Increase | +44.61% | 407.61K shares | 27.38M | $87.96 | 1.32M |
| Q1 2021 | share | Decrease | -13.76% | -145.74K shares | -29.97M | $97.23 | 913.70K |
| Q4 2020 | share | Decrease | -60.57% | -1.62M shares | -130.25M | $112.15 | 1.05M |
| Q3 2020 | share | Increase | +124.28% | 1.48M shares | 155.62M | $92.7 | 2.68M |
| Q2 2020 | share | Decrease | -2.29% | -28.10K shares | 21.74M | $78 | 1.19M |
| Q1 2020 | share | Decrease | -37.70% | -741.94K shares | -85.95M | $58.48 | 1.22M |
| Q4 2019 | share | Increase | +38.72% | 549.33K shares | 53.42M | $80.11 | 1.96M |
| Q3 2019 | share | Increase | +171.13% | 895.44K shares | 54.87M | $73.47 | 1.41M |
| Q2 2019 | share | Increase | +161.63% | 323.26K shares | 33.34M | $94.33 | 523.26K |
| Q1 2019 | share | Increase | 0.00% | 200K shares | 16.01M | $80.05 | 200K |
| Q4 2017 | share | Decrease | -100.00% | -313.96K shares | -21.87M | $75.41 | 0 |
| Q3 2017 | share | Decrease | -31.31% | -143.13K shares | -1.28M | $69.67 | 313.96K |
| Q2 2017 | share | Increase | +161.35% | 282.20K shares | 16.16M | $50.67 | 457.10K |
| Q1 2017 | share | Increase | 0.00% | 174.9K shares | 6.99M | $39.99 | 174.9K |